Irma Bagdoniene: Statin Intolerance – Challenges and Solutions
Irma Bagdoniene, Cardiologist Specializing in Prevention & Lipidology, shared on LinkedIn:
“Statin intolerance: a frequent clinical challenge, but far from a dead end.
True, confirmed statin intolerance with myopathy and CK elevation occurs in about 5% of patients reporting symptoms. Many are actually experiencing the well-documented nocebo effect.
For us, this does not mean stopping therapy. It means adapting our approach.
Most patients labeled ‘intolerant’ do well after switching to another statin (for example, hydrophilic rosuvastatin) or trying low-dose, alternate-day dosing.
For those truly intolerant, therapeutic options remain robust and effective:
• Ezetimibe lowers LDL-C by 15–20%
• Bempedoic acid reduces LDL-C by 15–25% without muscle-related symptoms
• PCSK9 inhibitors provide a powerful 50–60% LDL-C reduction
• Inclisiran, with just twice-yearly dosing, delivers sustained ~60% LDL-C lowering
The CLEAR-Outcomes trial also highlighted that in statin-intolerant patients, hsCRP may predict cardiovascular risk even better than LDL-C.
The take-home message: stopping lipid-lowering therapy should be avoided wherever possible. Re-challenge, switch agents, or refer to a lipid specialist — but never leave high-risk patients unprotected. •
A highly recommended statement on this from the National Lipid Association.”
Stay with Hemostasis Today to explore more from Irma Bagdoniene.
-
Feb 1, 2026, 11:50Wolfgang Miesbach on The 1st Case of Secondary Malignancy Triggered by Integrated AAV
-
Feb 1, 2026, 11:42Khokon Miah Akanda: 2026 Guideline for the Early Management of Patients With Acute Ischemic Stroke
-
Feb 1, 2026, 11:35Benjamin Terrier Shares A PhD Opportunity In Immunology
-
Feb 1, 2026, 11:32Qizhen Shi։ A Padua Moment for Factor VIII Gene Therapy
-
Feb 1, 2026, 11:25Abdul Mannan: Breaking Down the New BSH Hepatitis Guideline for Haemophilia Nurses
-
Feb 1, 2026, 11:24Nathan Wong on Economic Benefits of Inclisiran for LDL-C Control
-
Feb 1, 2026, 11:10Antonio Ciacciarelli Shares A Comparison of Pragmatic Post-Thrombectomy Prognostic Scores
-
Feb 1, 2026, 10:41Colm Dougan on The Blood Infection That Changed Medicine
-
Feb 1, 2026, 10:25Indunil Karunarathna Breaks Down The Cerebral Venous Sinus Thrombosis